Compare BAX & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BAX | HSIC |
|---|---|---|
| Founded | 1931 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 9.7B |
| IPO Year | 1994 | 1996 |
| Metric | BAX | HSIC |
|---|---|---|
| Price | $26.86 | $88.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 16 |
| Target Price | $21.00 | ★ $85.07 |
| AVG Volume (30 Days) | ★ 7.1M | 1.4M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.24% | N/A |
| EPS Growth | N/A | ★ 7.21 |
| EPS | 0.21 | ★ 1.74 |
| Revenue | $11,244,000,000.00 | ★ $13,201,995,000.00 |
| Revenue This Year | $1.96 | $6.12 |
| Revenue Next Year | $2.22 | $3.64 |
| P/E Ratio | $130.14 | ★ $51.49 |
| Revenue Growth | 5.72 | ★ 5.94 |
| 52 Week Low | $15.73 | $61.97 |
| 52 Week High | $30.00 | $92.18 |
| Indicator | BAX | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 69.65 | 68.98 |
| Support Level | $18.58 | $82.77 |
| Resistance Level | $30.00 | N/A |
| Average True Range (ATR) | 1.01 | 2.11 |
| MACD | 0.41 | 0.21 |
| Stochastic Oscillator | 70.70 | 75.86 |
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.